Literature DB >> 6600498

beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

A L Kovatch, E R Wald, R H Michaels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6600498     DOI： 10.1016/s0022-3476(83)80537-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  35 in total

1.  Evaluation of Bacto TB hydrolysis reagent (Tween 80) for the identification of Branhamella catarrhalis.

Authors:  M Weiner; P D Penha
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

2.  Efficacy and tolerability of cefixime in otitis media. A multicentre study in over 25,000 children.

Authors:  D H Wu
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.

Authors:  K Tunér; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

4.  Moraxella catarrhalis Might Be More Common than Expected in Acute Otitis Media in Young Finnish Children.

Authors:  Saara Sillanpää; Sami Oikarinen; Markku Sipilä; Lenka Kramna; Markus Rautiainen; Heini Huhtala; Janne Aittoniemi; Jussi Laranne; Heikki Hyöty; Ondrej Cinek
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

Review 5.  [Moraxella catarrhalis: virulence and resistance mechanisms].

Authors:  W Cullmann
Journal:  Med Klin (Munich)       Date:  1997-03-15

6.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 8.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

9.  Otitis media and sinusitis in children. Role of Branhamella catarrhalis.

Authors:  C D Bluestone
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 10.  The role of beta-lactamase-producing-bacteria in mixed infections.

Authors:  Itzhak Brook
Journal:  BMC Infect Dis       Date:  2009-12-14       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.